BB&T Securities’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $157K | Buy |
+22,824
| New | +$175K | ﹤0.01% | 1541 |
|
|
2018
Q4 | – | Sell |
-30,610
| Closed | -$659K | – | 1606 |
|
|
2018
Q3 | $659K | Sell |
30,610
-16,959
| -36% | -$394K | 0.01% | 965 |
|
|
2018
Q2 | $1.16M | Buy |
47,569
+22,574
| +90% | +$460K | 0.01% | 761 |
|
|
2018
Q1 | $427K | Sell |
24,995
-32,668
| -57% | -$638K | ﹤0.01% | 1086 |
|
|
2017
Q4 | $1.09M | Sell |
57,663
-55,280
| -49% | -$832K | 0.01% | 723 |
|
|
2017
Q3 | $1.99M | Buy |
112,943
+93,630
| +485% | +$2.11M | 0.03% | 531 |
|
|
2017
Q2 | $641K | Buy |
19,313
+8,708
| +82% | +$270K | 0.01% | 892 |
|
|
2017
Q1 | $340K | Buy |
10,605
+2,766
| +35% | +$94.4K | ﹤0.01% | 1007 |
|
|
2016
Q4 | $360K | Hold |
7,839
| – | – | 0.01% | 951 |
|
|
2016
Q3 | $360K | Sell |
7,839
-925
| -11% | -$48.3K | 0.01% | 951 |
|
|
2016
Q2 | $440K | Buy |
8,764
+579
| +7% | +$30.8K | 0.01% | 846 |
|
|
2016
Q1 | $437K | Sell |
8,185
-5,719
| -41% | -$336K | 0.01% | 812 |
|
|
2015
Q4 | $912K | Buy |
13,904
+7,569
| +119% | +$468K | 0.02% | 551 |
|
|
2015
Q3 | $357K | Sell |
6,335
-1,474
| -19% | -$95.6K | 0.01% | 806 |
|
|
2015
Q2 | $461K | Buy |
7,809
+106
| +1% | +$6.54K | 0.01% | 778 |
|
|
2015
Q1 | $4.8M | Sell |
7,703
-774
| -9% | -$45K | 0.01% | 729 |
|
|
2014
Q4 | $4.88M | Buy |
8,477
+133
| +2% | +$7.41K | 0.01% | 712 |
|
|
2014
Q3 | $4.48M | Sell |
8,344
-644
| -7% | -$34.1K | 0.01% | 715 |
|
|
2014
Q2 | $4.71M | Sell |
8,988
-1,719
| -16% | -$87.9K | 0.01% | 684 |
|
|
2014
Q1 | $5.66M | Sell |
10,707
-440,619
| -98% | -$20.4M | 0.01% | 560 |
|
|
2013
Q4 | $181M | Sell |
451,326
-154,416
| -25% | -$6.08M | 0.5% | 56 |
|
|
2013
Q3 | $229M | Buy |
605,742
+6,676
| +1% | +$260K | 0.71% | 48 |
|
|
2013
Q2 | $235K | Buy |
+599,066
| New | +$23.3M | 0.77% | 42 |
|
Other funds holding TEVA
ACM
CS
CA